Intervacc AB (publ)
STO: IVACC.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Carl-Johan Dalsgaard
- Employees
- 15
- Headquarters
- Hägersten, Sweden
- IPO year
- 2017
- Market cap
- SEK 424.7M
- Website
- https://www.intervacc.se
Loading IVACC…
Loading profile data…Frequently asked questions about IVACC
What does Intervacc AB (publ) (IVACC.ST) do?
Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles. The company also markets and sells veterinary medicines; and provides diagnostic s...
Where does IVACC.ST trade?
Intervacc AB (publ) (IVACC.ST) trades on the Stockholm Stock Exchange.
What sector is IVACC.ST in?
Intervacc AB (publ) (IVACC.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Intervacc AB (publ)?
Carl-Johan Dalsgaard is the chief executive officer of Intervacc AB (publ) (IVACC.ST).
Where is Intervacc AB (publ) headquartered?
Intervacc AB (publ) is headquartered in Sweden.
Does IVACC.ST pay a dividend?
Intervacc AB (publ) (IVACC.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVACC.ST go public?
Intervacc AB (publ) (IVACC.ST) completed its initial public offering in 2017.